Cullinan Therapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Cullinan Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2021 to Q3 2024.
  • Cullinan Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $9.43M, a 21.8% increase year-over-year.
  • Cullinan Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $35.7M, a 17.3% increase year-over-year.
  • Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $30.4M, a 8.87% increase from 2022.
  • Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $28M, a 14.7% increase from 2021.
  • Cullinan Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $24.4M, a 63.5% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $35.7M $9.43M +$1.69M +21.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $34M $10.5M +$2.61M +33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $31.4M $8.23M +$968K +13.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $30.4M $7.52M +$6K +0.08% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 $30.4M $7.74M +$2.47M +46.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $28M $7.92M -$688K -7.99% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $28.7M $7.26M +$694K +10.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $28M $7.51M -$4.63M -38.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 $32.6M $5.27M +$714K +15.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $31.9M $8.61M +$4.44M +107% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $27.4M $6.57M +$3.06M +87.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $24.4M $12.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 $4.56M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $4.17M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $3.51M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.